First Eagle Investment Management LLC Boosts Stock Position in Cardinal Health, Inc. (NYSE:CAH)

First Eagle Investment Management LLC raised its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 10,516 shares of the company’s stock after buying an additional 200 shares during the period. First Eagle Investment Management LLC’s holdings in Cardinal Health were worth $1,244,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Rothschild Investment LLC lifted its position in Cardinal Health by 10.1% during the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock valued at $101,000 after acquiring an additional 79 shares during the last quarter. Private Trust Co. NA increased its position in shares of Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after purchasing an additional 92 shares in the last quarter. Checchi Capital Advisers LLC lifted its holdings in shares of Cardinal Health by 2.7% during the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock valued at $411,000 after purchasing an additional 93 shares during the last quarter. MWA Asset Management boosted its position in shares of Cardinal Health by 2.9% in the 4th quarter. MWA Asset Management now owns 3,324 shares of the company’s stock worth $393,000 after purchasing an additional 95 shares in the last quarter. Finally, Transcend Capital Advisors LLC grew its stake in Cardinal Health by 3.6% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock worth $323,000 after buying an additional 96 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Up 1.5 %

Shares of CAH stock opened at $128.20 on Monday. The stock has a market cap of $30.97 billion, a PE ratio of 23.92, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84. The business has a 50-day simple moving average of $126.33 and a 200-day simple moving average of $119.44.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.58%. Cardinal Health’s dividend payout ratio (DPR) is currently 37.69%.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of research analyst reports. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and increased their price target for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Morgan Stanley upped their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, January 31st. Finally, Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.